Radiation therapy and hydroxyurea followed by the combination of 6- Thioguanine and BCNU for the treatment of primary malignant brain tumors

International Journal of Radiation Oncology Biology Physics

Volumn 40, Issue 1, 1998, Pages 57-63

  Prados, Michael D ^a,b   Larson, David A ^a   Lamborn, Kathleen ^a   McDermott, Michael W ^a   Sneed, Penny K ^a   Wara, William M ^a   Chang, Susan M ^a   Mack, Ellen E ^a   Krouwer, Hendrikus G J ^a   Chandler, Kym L ^a   Warnick, Ronald E ^a   Davis, Richard L ^a   Rabbitt, Jane E ^a   Malec, Mary ^a   Levin, Victor A ^a   Gutin, Phillip H ^a   Phillips, Theodore L ^a   Wilson, Charles B ^a  

^a Depts of Neurosurg Radiat O   (United States)

^b NONE   (United States)

Author keywords

6 Thioguanine; Anaplastic glioma; Glioblastoma multiforme; Hydroxyurea; Radiation therapy

Indexed keywords

CARMUSTINE; HYDROXYUREA; LIVER ENZYME; LOMUSTINE; PROCARBAZINE; PYRIMIDINE DERIVATIVE; TIOGUANINE; VINCRISTINE;

ADOLESCENT; ADULT; AGED; ARTICLE; BEAM THERAPY; BONE MARROW SUPPRESSION; CANCER SURVIVAL; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; GASTROINTESTINAL SYMPTOM; GLIOBLASTOMA; HUMAN; INTRATHECAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LUNG TOXICITY; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RADIATION DOSE; TUMOR GROWTH;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; CARMUSTINE; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; FEMALE; GLIOBLASTOMA; GLIOMA; HUMANS; HYDROXYUREA; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RADIOTHERAPY DOSAGE; SURVIVAL ANALYSIS; THIOGUANINE;

EID: 0031963150     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(97)00566-X     Document Type: Article

References (17)

1. Bodell W. J., Morgan W. F., Williams M. E., Deen D. F. Potentiation of 1,3-bis(-chloroethyl)-1-nitrosourea (BCNU)-induced cytotoxicity in 9L cells by pretreatment with 6-thioguanine. Biochem. Pharmacol. 34:1985;515-520.
2. Fugimoto S., Ogawa M., Sakurai Y. Hypothetical mechanism of therapeutic synergism of 6-thioguanine and 3-[(4-amino-2-methyl-5 pyrimidinyl)methyl]-1(2-chloroethyl)-1-nitrosourea hydrochloride. Cancer Res. 42:1982;4079-4085.
3. Halperin E. C., Herndon J., Schold S. C., Brown M., Vick N., Cairncross J. G., Macdonald D. R., Gaspar L., Fischer B., Dropcho E., Rosenfeld S., Morowitz R., Piepmeier J., Hait W., Byrne T., Salter M., Imperato J., Khandekar J., Paleologos N., Burger P., Bentel G., Friedman A. A phase III randomized prospective trial of external beam radiotherapy, mitomycin C, carmustin, and 6-mercaptopurine for the treatment of adults with anaplastic glioma of the brain. Int. J. Radiat. Oncol. Biol. Phys. 34:1996;793-802.
4. Hunter K. J., Deen D. F., Marton L. J. Differential response to 1,3-bis(2-chloroethyl)-1-nitrosourea in drug resistant and sensitive 9L cells by pretreatment with α-difloromethylornithine and 6-thioguanine. Biochem. Pharmacol. 34:1989;515-520.
5. Laramore G. E., Martz K. L., Nelson J. S., Griffin T. W., Chang C. H., Horton J. Radiation Therapy Oncology Group (RTOG) survival data on anaplastic astrocytomas of the brain Does a more aggressive form of treatment adversely impact survival? Int. J. Radiat. Oncol. Biol. Phys. 17:1989;1351-1356.
6. Levin V. A., Prados M. D. Treatment of recurrent gliomas and metastatic brain tumors with a polydrug protocol designed to combat nitrosourea resistance. J. Clin. Oncol. 10:1992;766-771.
7. Levin V. A., Prados M. D., Wara W. M., Davis R. L., Gutin P. H., Phillips T. L., Lamborn K., Wilson C. B. Radiation therapy and bromodeoxyuridine chemotherapy followed by procarbazine, lomustine, and vincristine for the treatment of anaplastic gliomas. Int. J. Radiat. Oncol. Biol. Phys. 32:1995;75-83.
8. Levin V. A., Silver P., Hannigan J., Wara W. M., Gutin P. H., Davis R. L., Wilson C. B. Superiority of postradiotherapy adjuvant chemotherapy with CCNU, procarbazine and vincristine (PCV) over BCNU for anaplastic gliomas NCOG 6G61 final report . Int. J. Radiat. Oncol. Biol. Phys. 18:1990;321-324.
9. Levin V. A., Wilson C. B., Davis R. L., Wara W. M., Pischer T. L., Irwin L. A. Phase III comparison study of BCNU, hydroxyurea and irradiation for the treatment of primary malignant gliomas. J. Neurosurg. 51:1979;526-532.
10. Lu K., Benvenuto J. A., Bodey G. P., Gottlieb J. A., Rosenblum V. G., Loo T. L. Pharmacokinetics and metabolism of bets-s-deoxythioguanosine and 6-thioguanine in man. Cancer Chemother. Pharmacol. 8:1982;119-123.
11. Phillips T. L., Levin V. A., Ahn D. K., Gutin P. H., Davis R. L., Wilson C. B., Prados M. D., Wara M. W., Flam M. S. Evaluation of bromodeoxyuridine in glioblastoma multiforme A Northern California Cancer Center Phase II Study . Int. J. Radiat. Oncol. Biol. Phys. 21:1991;709-714.
12. Prados M. D., Gutin P. H., Phillips T. L., Wara W. M., Larson D. L., Sneed P. K., Davis R. L., Ahn D. K., Lamborn K. L., Wilson C. B. Highly anaplastic astrocytoma a review of 357 patients treated between 1977 and 1989 . Int. J. Radiat. Oncol. Biol. Phys. 23:1992;3-8.
13. Scott C. B., Nelson J. S., Farnan N. C., Curran W. J., Murray K. J., Fisbach A. J., Gaspar L. E., Nelson D. F. Central pathology review in clinical trials for patients with malignant glioma. Cancer. 76:1995;307-313.
14. Smith D. C., Vick N. A., Trump D. L., Friedman H. S., Friedman H. A., Purvis J., Gauspari A., Schold S. C. Phase I study of BCNU and intravenous 6-mercaptopurine in patients with malignant glioma. Cancer Chemother. Pharmacol. 30:1992;272-276.
15. Sullivan F. J., Herscher L. L., Cook J. A., Smith J., Steinberg S. M., Epstein A. H., Oldfield E. H., Goffman T. E., Kinsella T. J., Mitchell J. B., Glatstein E. National Cancer Institute (phase II) study of high-grade glioma treated with accelerated hyperfractionated radiation and iododeoxyuridine results in anaplastic astrocytoma . Int. J. Radiat. Oncol. Biol. Phys. 30:1994;583-590.
16. Urtasun R. C., Cosmatos D., DelRowe J., Kinsella T. J., Lester S., Wasserman T., Fulton D. S. Iododeoxyuridine (IUdR) combined with radiation in the treatment of malignant glioma A comparison of short versus long intravenous dose schedules (RTOG 86-12) . Int. J. Radiat. Oncol. Biol. Phys. 27:1993;207-214.
17. Urtasun R. C., Kinsella T. J., Farnan N., DelRowe J. D., Lester S. G., Fulton D. S. Survival improvement in anaplastic astrocytoma, combining external radiation with halogenated prymidines Final report of RTOG 86-12, Phase I-II study . Int. J. Radiat. Oncol. Biol. Phys. 36:1996;1163-1167.